Publications

5674 Results

Trastuzumab Plus Pertuzumab Versus Cetuximab Plus Irinotecan in Patient with RAS/BRAF wild-type, HER2-positive, Metastatic Colorectal Cancer (S1613): A Randomized Phase 2 Trial

Authors
K Raghav;K Guthrie;B Tan;C Denlinger;M Fakih;M Overman;NA Dasari;L Corum;L Hicks;M Patel;B Esparaz;S Kazmi;N Alluri;S Colby;S Gholami;P Gold;EG Chiorean;ES Kopetz;H Hochster;PA Philip
Journal / Conference
Journal of Clinical Oncology Apr 10;43(11):1348-1357
Year
2025
Research Committee(s)
Gastrointestinal
PMID
PMID39761503
PMC
PMC11975499
Study Number(s)
S1613

Evaluating the impact of stratification on the power and cross-arm balance of randomized Phase 2 clinical trials

Authors
A Moseley;M LeBlanc;B Freidlin;R Shallis;A Zeidan;D Sallman;H Erba;R Little;M Othus
Journal / Conference
Clinical Trials 2025;0(0). doi:10.1177/17407745241304065
Year
2025
Research Committee(s)
Leukemia
Study Number(s)
MYELOMATCH

Augmenting Insufficiently Accruing Oncology Clinical Trials Using Generative Models: Validation Study

Authors
S El Kababji;N Mitsakakis;E Jonker;A Beltran-Bless;G Pond;L Vandermeer;D Radhakrishnan;L Mosquera;A Paterson;L Shepherd;B Chen;W Barlow;J Gralow;M Savard;C Fesl;D Hlauschek;M Balic;G Rinnerthaler;R Greil;M Gnant;M Clemons;K El Emam;B Eng
Journal / Conference
Journal of Medical Internet Research vol. 27 | e66821
Year
2025
Research Committee(s)
Breast
PMID
40053790
Study Number(s)
S0307

Health Care Contact Days for Older Adults Enrolled in Cancer Clinical Trials

Authors
A Gupta;C Till;R Vaidya;D Hershman;J Unger
Journal / Conference
JAMA Network Open Mar 3;8(3):e250778
Year
2025
Research Committee(s)
Cancer Care Delivery
PMID
PMID40080017
PMC
PMC11907310

When to Adjust for Multiplicity in Cancer Clinical Trials

Authors
J Unger;G Mazza;M Elsaid;F Duan;E Dressler;A Snavely;D Enserro;S Pugh
Journal / Conference
JNCI Monograph Mar 1;2025(68):3-9
Year
2025
Research Committee(s)
Cancer Care Delivery
PMID
PMID39989044
PMC
PMC11848029

Addressing Challenges in Research Aimed at Reducing Financial Toxicity Among Cancer Patients and Caregivers: An Example From the CREDIT Study (SWOG S1912CD)

Authors
A Bell-Brown;B Tawfik;B Segarra-Vazquez;T Hopkins;K Watabayashi;P O'Kane;R Carlos;S Langer;J Unger;A Darke;D Hershman;S Ramsey;V Shankaran
Journal / Conference
Cancer Control Jan-Dec:32:10732748251344469
Year
2025
Research Committee(s)
Cancer Care Delivery
PMID
PMID40384469
PMC
PMC12089715
Study Number(s)
S1912CD

Concordance Between Liquid and Tissue-Based Assessment of Somatic Homologous Recombination Deficiency (HRD) in Triple-Negative Breast Cancer (TNBC) from SWOG S1416 Trial

Authors
S Stecklein;W Barlow;J Tsai;A Yablonovitch;E Rodler;P Kuhn;J Hicks;H Pathak;D Hayes;J Rae;G Hortobagyi;A Thompson;A Godwin;L Pusztai;P Sharma
Journal / Conference
ASCO Annual Meeting (May 30 to June 3, 2025, Chicago, Il), oral
Year
2025
Research Committee(s)
Breast
Study Number(s)
S1416

Intracluster Correlation Coefficients from Cluster Randomized Trials Conducted within the NCI Community Oncology Research Program (NCORP)

Authors
A Snavely;H Gunn;J Lee;S Pugh;W Barlow;E Culacova;K Arnold;C Kittel;S Smith;B Hanlon;A Tan;T Dockter;D Zahrieh;E Dressler
Journal / Conference
JNCI Monographs Mar 1;2025(68):65-72
Year
2025
Research Committee(s)
Cancer Care Delivery
PMID
PMID39989039
PMC
PMC11848034
Study Number(s)
S1415CD

Probability of remission with reinduction with 7+3 versus high-dose ara-C: Analysis of SWOG Trial S1203

Authors
M Othus;G Garcia-Manero;F Appelbaum;H Erba;E Estey;M Percival
Journal / Conference
Leukemia
Year
2025
Research Committee(s)
Leukemia
PMID
PMID39870766
Study Number(s)
S1203

Chemotherapy Dose Density is Prognostic for Overall Survival in Patients with Resectable Pancreas Cancer: A Landmark Analysis of SWOG 1505

Authors
S Patel;S Colby;D Sohal;K Guthrie;L Kachnic;EG Chiorean;A Lowy;F Rocha;H Hochster;P Philip;S Ahmad
Journal / Conference
Cancer
Year
2025
Research Committee(s)
Gastrointestinal
PMID
PMID39932777
PMC
PMC11812894
Study Number(s)
S1505